{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:13:53Z","timestamp":1794089633530,"version":"4.8.0"},"reference-count":47,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008002","name":"Vancouver Coastal Health Research Institute","doi-asserted-by":"publisher","award":["Innovation&TranslationalResearchAward2016 VA-01638"],"award-info":[{"award-number":["Innovation&TranslationalResearchAward2016 VA-01638"]}],"id":[{"id":"10.13039\/501100008002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Richmond Hospital Foundation","award":["No award\/grant number"],"award-info":[{"award-number":["No award\/grant number"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2021,1,13]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To identify root causes of preventable adverse drug events (pADEs) contributing to hospital admission; to develop key messages which identify actions patients\/families and healthcare providers can take to prevent common pADEs found; to develop a surveillance learning system for the community.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cross-sectional observational study; 120 patients and families, 61 associated healthcare providers were interviewed then root cause analysis was performed to develop key learning messages and an electronic reporting tool was designed. Most common pADE-related medical conditions and their root causes and most common pADE root causes of entire cohort are reported.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Most common pADE-related medical conditions: chronic obstructive pulmonary disease\/asthma (13.3%), bleeding (12.5%), hypotension (12%), heart failure (10%), acute kidney injury (5%) and pneumonia (5%). Most common root causes were: providers not confirming that the patient\/family understands information given (29.2%), can identify how a medication helps them\/have their concerns addressed (16.7%), can identify if a medication is working (14.1%) or causing a side effect (23.3%); can enact medication changes (7.5%); absence of a sick day management plan (12.5%), and other action plans to help patients respond to changes in their clinical status (10.8%); providers not assessing medication use and monitoring competency (19.2%). Ten key learning messages were developed and a pADE surveillance learning system was implemented.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>To prevent pADEs, providers need to confirm that patients\/families understand information given, how a medication helps them, how to recognise and respond to side effects, how to enact medication changes and follow action plans; providers should assess patient\u2019s\/families\u2019 medication use and monitoring competency.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjoq-2020-001161","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T10:35:38Z","timestamp":1611570938000},"page":"e001161","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Preventable adverse drug events causing hospitalisation: identifying root causes and developing a surveillance and learning system at an urban community hospital, a cross-sectional observational study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-6895","authenticated-orcid":false,"given":"Jane","family":"de Lemos","sequence":"first","affiliation":[{"name":"Pharmacy, Richmond Hospital, Richmond, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Loewen","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Nagle","sequence":"additional","affiliation":[{"name":"Family Physician, Richmond, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McKenzie","sequence":"additional","affiliation":[{"name":"Family Physician, Richmond, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Dong","family":"You","sequence":"additional","affiliation":[{"name":"Internal Medicine, Richmond Hospital, Richmond, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dabu","sequence":"additional","affiliation":[{"name":"Internal Medicine, Nanaimo Regional General Hospital, Nanaimo, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zed","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ling","sequence":"additional","affiliation":[{"name":"Internal Medicine, Richmond Hospital, Richmond, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Chan","sequence":"additional","affiliation":[{"name":"Emergency Department, Richmond Hospital, Richmond, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2025083113063303000_10.1.e001161.1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1071\/AH12027","article-title":"Hospital admissions caused by adverse drug events: an Australian prospective study","volume":"38","author":"Phillips","year":"2014","journal-title":"Aust Health Rev"},{"key":"2025083113063303000_10.1.e001161.2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s13054-014-0643-5","article-title":"A systematic review of adult admissions to ICUs related to adverse drug events","volume":"18","author":"Jolivot","year":"2014","journal-title":"Crit Care"},{"key":"2025083113063303000_10.1.e001161.3","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831060-00009"},{"key":"2025083113063303000_10.1.e001161.4","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L037"},{"key":"2025083113063303000_10.1.e001161.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1316-4"},{"key":"2025083113063303000_10.1.e001161.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1630-5"},{"key":"2025083113063303000_10.1.e001161.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"2025083113063303000_10.1.e001161.8","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.215"},{"key":"2025083113063303000_10.1.e001161.9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03319101","article-title":"Adverse drug events as a cause of hospitalization in older adults","volume":"35 Suppl 1","author":"Salvi","year":"2012","journal-title":"Drug Saf"},{"key":"2025083113063303000_10.1.e001161.10","doi-asserted-by":"publisher","DOI":"10.1136\/qhc.12.4.280"},{"key":"2025083113063303000_10.1.e001161.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02698.x"},{"key":"2025083113063303000_10.1.e001161.12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2013.10.006","article-title":"Risk factors associated with adverse drug events among older adults in emergency department","volume":"25","author":"Chen","year":"2014","journal-title":"Eur J Intern Med"},{"key":"2025083113063303000_10.1.e001161.13","first-page":"1875","article-title":"Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients","volume":"22","author":"Chan","year":"2014","journal-title":"Support Care Cancer"},{"key":"2025083113063303000_10.1.e001161.14","article-title":"30-Day potentially avoidable readmissions due to adverse drug events","author":"Dalleur","year":"2017","journal-title":"J Patient Saf"},{"key":"2025083113063303000_10.1.e001161.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1103053"},{"key":"2025083113063303000_10.1.e001161.16","first-page":"505","article-title":"Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization","volume":"6","author":"Perrone","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"2025083113063303000_10.1.e001161.17","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A225"},{"key":"2025083113063303000_10.1.e001161.18","unstructured":"The third who global safety challenge: medication without harm. Geneva, 2020. Available: https:\/\/www.who.int\/patientsafety\/medication-safety\/en\/ [Accessed March 2020]."},{"key":"2025083113063303000_10.1.e001161.19","unstructured":"U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion . National action plan for adverse drug event prevention. Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion, 2014."},{"key":"2025083113063303000_10.1.e001161.20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PTS.0000000000000072","article-title":"Root cause analysis of ambulatory adverse drug events that present to the emergency department","volume":"12","author":"Gertler","year":"2016","journal-title":"J Patient Saf"},{"key":"2025083113063303000_10.1.e001161.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"2025083113063303000_10.1.e001161.22","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2005.017616"},{"key":"2025083113063303000_10.1.e001161.23","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2025083113063303000_10.1.e001161.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-10-200405180-00017"},{"key":"2025083113063303000_10.1.e001161.25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11596570-000000000-00000","article-title":"Methods for assessing the preventability of adverse drug events: a systematic review","volume":"35","author":"Hakkarainen","year":"2012","journal-title":"Drug Saf"},{"key":"2025083113063303000_10.1.e001161.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00199.x"},{"key":"2025083113063303000_10.1.e001161.27","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"key":"2025083113063303000_10.1.e001161.28","unstructured":"Patton MQ , Interviewing Q . In:Patton MQ editor. In: Qualitative research and evaluative methods: integrating theory and practice. 4th ed.2015. Thousand Oaks: Sage Publications Inc, 2012: 423\u2013516."},{"key":"2025083113063303000_10.1.e001161.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2003.10651.x"},{"key":"2025083113063303000_10.1.e001161.30","first-page":"40","article-title":"A short form of the Taiwan health literacy scale (THLS) for Chinese speaking adults","volume":"4","author":"Pan","year":"2010","journal-title":"International Journal of Social, Behavioural, Educational, Economic, Business and Industrial Engineering"},{"key":"2025083113063303000_10.1.e001161.31","first-page":"588","article-title":"Brief questions to identify patients with inadequate health literacy","volume":"36","author":"Chew","year":"2004","journal-title":"Fam Med"},{"key":"2025083113063303000_10.1.e001161.32","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-198601000-00007"},{"key":"2025083113063303000_10.1.e001161.33","doi-asserted-by":"publisher","DOI":"10.1177\/109019819001700303"},{"key":"2025083113063303000_10.1.e001161.34","first-page":"258","article-title":"Improving the measurement of patient self-reported medication non-adherence","volume":"64","author":"Morisky","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2025083113063303000_10.1.e001161.35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4212\/cjhp.v65i2.1118","article-title":"Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease","volume":"65","author":"Batterink","year":"2012","journal-title":"Can J Hosp Pharm"},{"key":"2025083113063303000_10.1.e001161.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2025083113063303000_10.1.e001161.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2025083113063303000_10.1.e001161.38","unstructured":"Rooney J , Van den Heuvel L . Root cause analysis for beginners. Quality Progress 2004:45\u201353."},{"key":"2025083113063303000_10.1.e001161.39","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071594"},{"key":"2025083113063303000_10.1.e001161.40","unstructured":"Patton MQ . Chapter 8, Qualitative Analysis and Interpretation. In: Qualitative research and evaluative methods: integrating theory and practice. 4th ed. Thousand Oaks: Sage Publications, 2015: 518\u2013651."},{"key":"2025083113063303000_10.1.e001161.41","doi-asserted-by":"publisher","DOI":"10.1177\/001316446002000104"},{"key":"2025083113063303000_10.1.e001161.42","unstructured":"Always use TeachBack! National Institute of healthcare improvement. Boston, Massachusetts, 2020. Available: http:\/\/www.ihi.org\/resources\/Pages\/Tools\/AlwaysUseTeachBack!.aspx [Accessed March 2020]."},{"key":"2025083113063303000_10.1.e001161.43","unstructured":"Canadian Institute for Health Information . All-Cause readmission to acute care and return to the emergency department. Ottawa, ON: Canadian Institute Health Information, 2012."},{"key":"2025083113063303000_10.1.e001161.44","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2011-200482"},{"key":"2025083113063303000_10.1.e001161.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2018-008664"},{"key":"2025083113063303000_10.1.e001161.46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bcp.14139","article-title":"Preventable adverse drug events: descriptive epidemiology","volume":"86","author":"Woo","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2025083113063303000_10.1.e001161.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2016-005511"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2020-001161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T20:06:44Z","timestamp":1756670804000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2020-001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,25]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bmjoq-2020-001161"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2020-001161","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}